Literature DB >> 28866295

The psychometric properties of depression screening tools in primary healthcare settings: A systematic review.

Sarira El-Den1, Timothy F Chen2, Yuh-Lin Gan2, Eling Wong2, Claire L O'Reilly2.   

Abstract

BACKGROUND: Consensus on a tool for depression screening among adults in primary healthcare (PHC) settings is lacking. This systematic review aimed to explore the psychometric properties of depression screening tools.
METHODS: A systematic literature search composed of four terms (screening AND psychometric AND depression AND primary healthcare) was conducted in PubMed, EMBASE, PsycINFO and MEDLINE, between January 1995 through October 2015. Studies that aimed to psychometrically test a depression screening tool among the general adult population in a PHC setting were included. Studies exploring the diagnostic properties of depression screening tools among specific populations were excluded.
RESULTS: Sixty publications, evaluating the psychometric properties of 55 tools or adaptations, were included. Studies were conducted in 24 countries and 18 languages on 48234 adults. The Patient Health Questionnaire-9 was the most evaluated tool with 14 studies evaluating its psychometric properties. Fifty-four studies reported on at least one measure of receiver operating characteristics. Sensitivity and specificity values ranged from 28% to 100% and 43% to 100%, respectively. Cronbach alpha values ranged from 0.56 to 0.94. Other forms of reliability and validity testing were less consistently and commonly reported. LIMITATIONS: The inclusion of studies regardless of methodological quality or design may have limited generalizability, but allowed for a comprehensive and detailed overview of the current literature.
CONCLUSIONS: Depression screening tools vary in their psychometric properties. The PHQ-9 was the most extensively psychometrically tested tool. This systematic review may aid PHC professionals in choosing a depression screening tool for universal use as it provides a comprehensive overview of their psychometric properties.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Depression; Primary healthcare; Psychometric; Screening

Mesh:

Year:  2017        PMID: 28866295     DOI: 10.1016/j.jad.2017.08.060

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  16 in total

Review 1.  Selecting Patient-Reported Outcome Measures to Contribute to Primary Care Performance Measurement: a Mixed Methods Approach.

Authors:  San Keller; Sydney Dy; Renee Wilson; Vadim Dukhanin; Claire Snyder; Albert Wu
Journal:  J Gen Intern Med       Date:  2020-06-03       Impact factor: 5.128

2.  The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.

Authors:  Charles N Bernstein; Lixia Zhang; Lisa M Lix; Lesley A Graff; John R Walker; John D Fisk; Scott B Patten; Carol A Hitchon; James M Bolton; Jitender Sareen; Renée El-Gabalawy; James Marriott; Ruth Ann Marrie
Journal:  Inflamm Bowel Dis       Date:  2018-08-16       Impact factor: 5.325

3.  Psychometric properties of screening questionnaires to detect depression in primary healthcare setting in rural Ethiopia.

Authors:  Kassahun Habtamu; Rahel Birhane; Girmay Medhin; Charlotte Hanlon; Abebaw Fekadu
Journal:  BMC Prim Care       Date:  2022-06-02

4.  A Prospectively Validated Nomogram for Predicting the Risk of PHQ-9 Score ≥15 in Patients With Erectile Dysfunction: A Multi-Center Study.

Authors:  Yu Zheng; Ming Gao; Guangdong Hou; Niuniu Hou; Xiao Feng; Tommaso B Jannini; Di Wei; Wanxiang Zheng; Lei Zhang; Xinlong Dun; Geng Zhang; Fuli Wang; Ping Meng; Emmanuele A Jannini; Jianlin Yuan
Journal:  Front Public Health       Date:  2022-06-17

5.  Evaluating the Use of Self-reported Measures in Autistic Individuals in the Context of Psychiatric Assessment: A Systematic Review.

Authors:  Soo Youn Kim; Luc Lecavalier
Journal:  J Autism Dev Disord       Date:  2021-10-13

6.  The BODY-Q Chest Module: Further Validation in a Canadian Chest Masculinization Surgery Sample.

Authors:  Anne F Klassen; Giancarlo McEvenue; Yi Wang; Charlene Rae; Manraj Kaur; Natasha Johnson; Kinusan Savard; John Semple; Andrea Pusic
Journal:  Aesthet Surg J       Date:  2021-04-12       Impact factor: 4.283

7.  Substance Use, Gambling, Binge-Eating, and Hypersexuality Symptoms Among Patients Receiving Opioid Agonist Therapies.

Authors:  Meagan M Carr; Jennifer D Ellis; Karen K Saules; Jamie L Page; Angela Staples; David M Ledgerwood
Journal:  Am J Addict       Date:  2021-03-30

8.  Perceptions of Risk, Work, and Lifestyle Changes on Mental Health of Healthcare Workers Amidst the COVID-19 Pandemic.

Authors:  Awatef Ergai; LeeAnna Spiva; Lin Li; Ryan Breshears; Ginny Zhan
Journal:  Int J Environ Res Public Health       Date:  2022-04-29       Impact factor: 3.390

9.  Diagnosis and Management of Depression in CRS: A Knowledge, Attitudes and Practices Survey.

Authors:  Amarbir S Gill; Joshua M Levy; Machelle Wilson; E Bradley Strong; Toby O Steele
Journal:  Int Arch Otorhinolaryngol       Date:  2020-04-24

10.  Validity of the PHQ-9 and PHQ-2 to screen for depression in nationwide primary care population in Latvia.

Authors:  Elmars Rancans; Marcis Trapencieris; Rolands Ivanovs; Jelena Vrublevska
Journal:  Ann Gen Psychiatry       Date:  2018-08-02       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.